Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  liposome-incorporated Grb2 antisense oligodeoxynucleotide
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With LDAC in Patients With Previously Untreated AML
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BP1001-201-AML, NCI-2016-00884, NCT02781883
Start Over